Cerebral blood flow in the rat was monitored by a venous outflow technique with an extracorporeal circulation, which allows for the continuous recording of flow over periods of several hours. The adenosine de aminase inhibitors erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) (1.0-100 fLg/kg) and deoxycoformycin (0.1-1 fLg/kg) potentiated the reactive hyperemia elicited by a brief (24-s) anoxic challenge. Basal flow rate was unal-Abbreviation used: EHNA. erythro-9-(2-hydroxy-3nonyl)adenine. in the regulation of cerebral blood flow. J Cereb B/ood FlolI' Metabol 1 :239-244 Wu PH. Phillis JW (1982) Uptake of adenosine by isolated rat brain capillaries. J NClIroc/zem 38:687 -690 Zetterstrom T, Vernet L, Ungerstedt U, To ssman U, Jonzon B, Fredholm BB (1982) Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett 29:111-115
Evidence for a major role of adenosine in the reg ulation of cerebral blood flow in the ischemic or hypoxic brain has accumulated steadily since the original proposal by Berne et ai. (1974) . Thus, aden osine is produced in the brain during hypoxia and ischemia (Berne et al., 1974; Nordstrom et al., 1977; Winn et ai., 1979 Winn et ai., , 1981 and, when applied directly to cerebral vessels, causes vasodilatation (Berne et ai., 1974; Wahl and Kuschinsky, 1976) . The threshold for adenosine's relaxant effects on vas cular smooth muscle lies at � 1 j..L M (Berne et ai., 1983) , which appropriately coincides with the ex tracellular level of adenosine in the striatum of nor moxic rats (�1 j..L M) (Zetterstrom et ai., 1982) . It can be speculated that whereas adenosine would play only a minor role in the regulation of cerebral blood flow in the normoxic brain, during hypoxia or ischemia the rise in extracellular adenosine (>4 f-LM) (Zetterstrom et al., 1982) would result in va sodilatation. Pharmacological confirmation that aden osine is involved in the hyperemic response to ce rebral hypoxia has been forthcoming in experiments in which the adenosine antagonists, theophylline and caffeine, were observed to blunt this response tered by EHNA administration and slightly enhanced by deoxycoformycin. The results are consistent with the hy pothesis that adenosine plays a significant role in cerebral vascular regulation and suggest that low doses of these deaminase inhibitors may be useful in the treatment of cerebral vascular insufficiency. Key Words: Adenosine deaminase-Anoxia-Cerebral blood flow-Deoxyco formycin-Erythro-9-(2-hydroxy-3-nonyl)adenine. (Emerson and Raymond, 1981; Berne et ai., 1983; Phillis et al., 1984) . Dipyridamole and papaverine, which inhibit adenosine uptake and thus its removal from the extracellular space by rat brain microves sels and synaptosomes (Phillis and Wu, 1982; Wu and Phillis, 1982) , enhanced anoxia-induced hyper emia in rat brains (Phillis et al., 1984) . Lidoflazine, another potent adenosine uptake inhibitor, also in creased the hyperemic response to an anoxic chal lenge (J. W. Phillis, et al., unpublished observa tions) .
An alternative route by which the brain can dis pose of adenosine is by its deamination into an in active metabolite, inosine. Adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4), the en zyme responsible for the conversion, is widely dis tributed in rat and human brain (Phillips and Newsholme, 1979; Norstrand et al., 1984) . In the present experiments, rats were administered two potent specific inhibitors of this enzyme, deoxycoformycin and erythro-9-(2-hydroxy-3-non yl)adenine (EHN A) (Henderson et al., 1977; Skolnick et ai., 1978; Agarwal, 1982) . Both com pounds enhanced the hyperemia elicited by brief anoxic challenges, providing further support for the hypothesis that adenosine plays a significant role in the control of cerebral vascular resistance and thus of cerebral bl{)od flow.
In this study, we have used a venous outflow technique to measure rat cerebral blood flow and its response to brief periods of anoxia. The method involves cannulation of a retroglenoid vein and has the advantage of allowing continuous recording of cerebral blood flow over periods of several hours, during which manipulations of blood gases can be conducted in the presence or absence of pharma cological agents (Berne et a!., 1983; Nilsson and Siesjo, 1983; Phillis et a!., 1984) .
METHODS

Preparation and recording
Cerebral blood flow measurements were performed on 21 male Sprague-Dawley rats (350-400 g; Charles River). Anesthesia was induced with 3% halothane to allow tra cheotomy, and the animals were then maintained during surgery on a mixture of nitrogen (70%), oxygen (30%), and methoxyflurane. Body temperature was maintained at 37°C with a heating pad controlled by a rectal probe. One femoral artery and one femoral vein were cannu lated. The artery cannula was used to record arterial blood pressure to obtain periodic small samples (0.4 ml) of arterial blood for pH and blood gas analysis. The vein cannula was used to return cerebral venous blood to the animal. The animal was then heparinized (l U/g body weight).
The right retroglenoid vein was exposed through a skin incision placed in front of the external auditory meatus after division of the temporal is muscle. A loose ligature was placed on the right retroglenoid vein on the cranial side of the large facial and retroauricular veins that con nect with it. The left retroglenoid vein was then exposed and freed from the surrounding tissues at its exit through the retroglenoid foramen. On this side, a ligature was tied into position to prevent reflux of venous blood into the transverse sinus from the extracranial veins, and the small facial veins emptying into the retroglenoid vein were coagulated. An angiocatheter (22 gauge, 1 in; De seret) was inserted into the retroglenoid vein and ad vanced in a retrograde direction until its tip was flush with the opening of the retroglenoid foramen. The angio catheter was tied into place in the retroglenoid vein using 6-0 suture thread. The extracorporeal venous flow system was then established. The femoral catheter was connected to a drop-recording chamber via tubing that passed through an adjustable roller pump. The drop chamber and extracorporeal tubing were filled with blood from a donor animal to prevent blood loss from the ex perimental animal. Blood in the extracorporeal circuit was warmed with a heat lamp. Blood from the retrogle noid vein flowed through the drop counter into the drop chamber and thus back to the animal. The height of the end of the drainage tube attached to the retroglenoid an giocatheter was adjusted to be level with the retroglenoid foramen.
Once flow through the extracorporeal circuit had started, the contralateral (right) retroglenoid vein was oc cluded by tying off the previously placed ligature to en sure that the venous blood from the transverse sinus drained through the angiocatheter and was not contami nated by extracranial blood from the contralateral side of the head. The animal was then administered pancuronium bromide (Pavulon, 1 mg/kg), connected to a ventilator, and respired at a frequency of 60-80 strokes/min with a J Cereb Blood Flow Metabol, Vol. 5, No.2, 1985 gas mixture of methoxyflurane (0.4%) in 30-40% oxygen and nitrogen. A period of 15-20 min was allowed for blood pressure and blood gases to stabilize. Mean arterial pressures were between 105 and 135 mm Hg. The mean (:±: SEM) values for blood gases in the 11 rats used to test for the effects of EHNA were PaoZ 147.4 :±: 8.0 mm Hg and Paco2 34.0 :±: 2.9 mm Hg, with a pH of 7.41 :±: 0.04. Blood gases for the six rats tested with deoxycoformycin were PaoZ 159.9 :±: 11.0 mm Hg and PaCOZ 40.8 :±: 5.7 mm Hg, with a pH of 7.35 :±: 0.06. Additional doses of heparin and pancuronium bromide were administered as required. Drop rate and arterial blood pressure were recorded on a Grass polygraph.
Following stabilization, the animals were administered a series of anoxic challenges. Oxygen flow was occluded for periods of 24 s, and at the same time, the nitrogen concentration was increased to 100%. The total flow rate remained constant. In this way, the animals were ren dered anoxic, without any accompanying hypercapnia. Blood gas measurements on animals in a related series of experiments showed that PaoZ fell to �32 mm Hg during the anoxic episode, whereas PaCOZ and pH values were not significantly altered. An interval of at least 15 min was allowed between anoxic challenges.
Data analysis
The data obtained in these experiments are expressed as the percentage of change in cerebral blood flow and the time to recovery following an anoxic challenge. Base line flow rates were measured as the number of drops occurring in the minute preceding the anoxic challenge. Owing to the "dead space" (anesthetic jar, respiratory pump, connecting tubing) in the respiratory circuit, there was a delay of � 15 s before the animals started to respond to the anoxic challenge. Thus, the start of the anoxic challenge was defined as that point at which there was a change in either arterial blood pressure or cerebral blood fl ow. Peak flow rate represents the rate of flow achieved during the period of anoxia, and the percentage change in cerebral blood flow is calculated from the formula, % increase in flow = [(peak flow rate -7 baseline flow rate)
x 100] -100. Recovery time represents the time from the end of the anoxic challenge until the flow rate re turned to pre anoxic levels.
In evaluating the effects of EHNA and deoxycofor mycin on cerebral blood flow during anoxia, the response to anoxia immediately preceding an intraperitoneal drug administration was compared with the response 15-20 min following intraperitoneal drug administration in 0.9% saline. Drug effects were analyzed by comparisons be tween control data and results at each dosage using Stu dent's t test for within-subject data. Results are presented as the means:±: SEM. EHNA at 1 fLg/kg was administered to four rats; EHNA 10 fLg/kg to five rats, one of which had previously received the lower dose; EHNA 100 fLg/ kg to five rats, two of which had already received a 10-fLg/kg dose. Deoxycoformycin 0.1 fLg/kg was adminis tered to six rats and 1 fLg/kg to four. When used, the second drug dose was administered after an interval of �45 min, following two anoxic challenges. Neither com pound altered mean arterial blood pressure. Another group of four control rats was utilized in an identical manner, except that these received successive doses of 0.9% saline intraperitoneally, with no adenosine deami nase inhibitors. 
RESULTS
Basal cerebral blood flow
The relationship between drop rate and blood flow rate has been ascertained in a previous study (Phillis et aI., 1984) . For a wide range of drop rates, there is a linear relationship between rate and flow per minute.
The mean predrug resting flow rates for the three EHNA groups were 21.4 ± 2.8, 25.0 ± 2.4, and 25.36 ± 3.4 drops/min. These flow rates were un altered by EHNA administration. Deoxycofor mycin caused an increase in resting flow rate in three of the six animals tested. The mean predrug flow rate of 32.6 ± 2.7 drops/min increased to 39.5 ± 6.9 drops/min after administration of deoxyco formycin (1 fLg/kg; p > 0.1).
Responses to anoxia
Ty pical control responses to 24-s anoxic chal lenges are illustrated in Figs. IA and 2A. The ef fects of brief periods of anoxia on arterial blood pressure varied from animal to animal but were rel atively reproducible in a given animal. A frequent pattern of response was a series of small fluctua tions in arterial blood pressure, often culminating in a brief fall in pressure at the termination of the anoxic challenge. Venous outflow increased, coin cident with the onset of the changes in arterial blood pressure, and then declined slowly to control levels. The increases in cerebral blood flow elicited by re peated anoxic challenges to a control group of four rats at IS-min intervals were reproducible over pe riods of �2 h (Group 1, in Ta ble 1).
EHNA
When administered intraperitoneally in doses of 1.0, 10, and 100 fLg/kg, EHNA enhanced both the percentage increase in peak flow and the time for flow rates to return to control level (Table 1) . The increase in peak flow was significant at 1.0-and 10-fLg/kg doses of EHNA, and the prolongation of re covery time was significant at all three doses. An example of the effect of EHNA is presented in Fig.  lB . After administration of EHNA 0.0 fLg/kg), the hyperemic response to an anoxic challenge was po tentiated in both intensity and duration.
Deoxycoformycin
The results with deoxycoformycin (0.1 and 1.0 fLg/kg) differed from those observed with EHNA, in that the percentage increase in peak flow rate was not altered even though the recovery time was sig nificantly prolonged at both doses (Table 1 ). In the example of deoxycoformycin action presented in Fig. 1B , there was an increase in peak flow rate, but this effect was not observed consistently. The lack of consistent change in percentage increase in flow is likely to have been a consequence of the increase in resting cerebral blood flow observed with this compound (but not with EHNA), which would have had the effect of reducing the per centage increase in peak flow during an anoxia chal lenge.
DISCUSSION
The significant findings in this study are that two potent, specific inhibitors of the enzyme adenosine deaminase, EHNA and deoxycoformycin (Hen derson et aI., 1977; Agarwal, 1982) , potentiate the cerebral hyperemia elicited by a brief episode of anoxia. Deoxycoformycin also increased resting ce rebral blood flow in several animals.
Adenosine deaminase, the enzyme that converts adenosine to its inactive metabolite, inosine, is widely distributed in the brain (Norstrand et aI., 1984) . It is also present in blood (Arch and News holme, 1978) . It can be anticipated that adenosine deaminase, together with the transport/uptake mechanism by which adenosine is absorbed into cells, serves to regulate the extracellular levels of adenosine in contact with cerebral blood vessels. Inhibition of adenosine deaminase would allow for an accumulation of adenosine in the vicinity of the cerebral resistance vessels, with vasodilatation and an increase in cerebral blood flow. In a previous pUblication, which described the rat venous outflow techniques for measuring cerebral blood flow, we reported that caffeine greatly attenuated the hyper emic response to an anoxic challenge, whereas the adenosine uptake inhibitors dipyridamole and pa paverine potentiated the response (Phillis et aI., 1984) . These results were presented as evidence for the hypothesis that adenosine is an important reg ulator of vascular tone in the hypoxic brain (see also Berne et aI., 1974; Winn et aI., 198 1) . The present results add further support to this hypothesis. The literature contains few references to the cen tral effects of adenosine deaminase inhibitors. EHNA has been demonstrated to enhance the ef flux of adenosine from normoxic and hypoxic rat brains (Zetterstrom et aI., 1982) and has a sedative effect in mice (Skolnick et aI., (978) . Deoxycofor mycin has been used in the treatment of acute lym phoblastic leukemia, and lethargy has been a fre quent central nervous system side effect of the treatment (Major et al., 198 1 patients treated with deoxycoformycin show ditfuse slowing of brain electrical activity, which could be due to an accumulation of adenosine in the brain. In addition, deoxycoformycin increases both rapid eye movement and slow wave sleep in rats (Virus et al., 1983) . Both compounds potentiate the de pressant actions of adenosine on the spontaneous firing of rat cerebral cortical neurons, and can have a depressant action on neuronal firing (Phillis et aI., 1979) . Neither drug appears to have been previ ously tested for its effects on cerebral blood flow. Coformycin, a related inhibitor of adenosine de aminase, is capable of potentiating the depressant action of adenosine on the electrical and mechanical activity of the atrial myocardium in guinea pigs (Szentmiklosi et aI., 1982) . It also enhances the myocardial actions of hypoxia, including reduction in the duration of action potentials, decrease in ten sion, and reduced velocity of contraction (Szent miklosi et aI., 1984) . These authors interpreted these actions of hypoxia as the result of the in creased tissue levels of adenosine. The effects of adenosine deaminase inhibitors on coronary blood flow in the normoxic and hypoxic heart also do not appear to have been extensively investigated.
In conclusion, the results of the present experi ments favor the assumption that in ischemia/anoxia, the increased tissue levels of adenosine play a sig nificant role in the autoregulation of the cerebral vasculature. Moreover, the results confirm that deoxycoformycin and EHNA, as potent and highly specific inhibitors of adenosine deaminase, can serve as useful and specific pharmacological tools in revealing the significance of the actions of en dogenous adenosine under various physiological and pathological conditions. Finally, they suggest that inhibitors of adenosine deaminase may be valu able agents for the treatment of diseases involving cerebral vascular insufficiency.
